Showing results (771-780 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.Neuro-Oncology|May 12, 2026
Intracranial Progression-Free Survival Correlates with Overall Survival and Varies by Tumor Subtype in Patients with Breast Cancer and Brain MetastasesSarah L Sammons, Ryan Shanley, Carey K Anders, et al.Neuro-Oncology|June 28, 2021
EANO guideline on the diagnosis and management of meningiomasRoland Goldbrunner, Pantelis Stavrinou, Michael D Jenkinson, et al.Neuro-Oncology|February 1, 2023
Application of radiomics to meningiomas: A systematic reviewRuchit V Patel, Shun Yao, Raymond Y Huang, et al.Neuro-Oncology|February 18, 2020
Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of ageBree R Eaton, Saveli Goldberg, Nancy J Tarbell, et al.Neuro-Oncology|October 17, 2017
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastomaPhilipp Kickingereder, Ulf Neuberger, David Bonekamp, et al.Neuro-Oncology|June 15, 2026
Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastomaDiogo Moniz Garcia, Wan-Hsin Lin, Daniel P Wickland, et al.Neuro-Oncology|February 6, 2013
Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade gliomaPeter S LaViolette, Alex D Cohen, Melissa A Prah, et al.Neuro-Oncology|June 30, 2026
The clinical and molecular landscape of thalamic gliomaLinpeng Zhang, Hesong Wang, Guangrui Huang, et al.Neuro-Oncology|June 29, 2026
Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline GliomaStefanie-Grace Sbergio, Huazhu Liang, Lucy Chen, et al.Pageof 315